Table 4.
Categorical moderators of the effect of improving sleep on composite mental health outcomes.
Variable | Levels | k | g+ | 95% CI | Q |
---|---|---|---|---|---|
Significant effect on sleepa | Yes | 72 | −0.53 | −0.69 to −0.38 | 17.69∗∗∗ |
No | 31 | −0.12 | −0.24 to 0.01 | ||
Clinical status of MH | Clinical | 15 | −0.72 | −1.14 to −0.30 | 0.92 |
Non-clinical | 45 | −0.50 | −0.68 to −0.31 | ||
Comorbidities | Mental health | 18 | −0.64 | −1.00 to −0.29 | 0.63 |
Physical health | 20 | −0.54 | −0.76 to −0.32 | ||
No comorbidities | 31 | −0.47 | −0.72 to −0.23 | ||
Follow-up point | Short (<6 months) | 61 | −0.60 | −0.77 to −0.42 | 10.75∗∗ |
Long (≥6 months) | 11 | −0.18 | −0.36 to −0.00 | ||
Assessment type | Self-reported | 66 | −0.54 | −0.70 to −0.38 | 0.62 |
Clinician rated | 6 | −0.44 | −0.65 to −0.23 | ||
Adjusted data | Adjusted | 21 | −0.51 | −0.77 to −0.26 | 0.01 |
Unadjusted | 51 | −0.53 | −0.72 to −0.35 | ||
Recruitment setting | Clinical (MH) | 12 | −0.52 | −1.00 to −0.04 | 3.72 |
Clinical (PH) | 14 | −0.52 | −0.76 to −0.28 | ||
Community | 39 | −0.39 | −0.53 to −0.26 | ||
Mixed | 9 | −1.12 | −1.94 to −0.31 | ||
Recruitment method | Voluntary | 49 | −0.46 | −0.58 to −0.34 | 0.98 |
Health professional | 7 | −0.65 | −1.45 to 0.14 | ||
Mixed | 8 | −0.88 | −1.80 to 0.04 | ||
Control group | Active control | 34 | −0.58 | −0.87 to −0.30 | 0.57 |
TaU | 13 | −0.52 | −0.75 to −0.29 | ||
Wait-list | 25 | −0.46 | −0.63 to −0.29 | ||
Risk of bias | High | 31 | −0.38 | −0.56 to −0.21 | 0.74 |
Low | 10 | −0.55 | −0.91 to −0.20 | ||
Intervention type | Acupuncture | 7 | −1.17 | −2.08 to −0.25 | 2.46 |
CBTi | 53 | −0.44 | −0.59 to −0.29 | ||
Exercised basedb | 4 | −0.52 | −0.85 to −0.19 | ||
Pharmacologicalc | 2 | – | – | ||
Sleep hygiene onlyc | 2 | – | – | ||
Sleep restriction onlyc | 1 | – | – | ||
CBT for nightmaresc | 1 | – | – | ||
Herbal teac | 1 | – | – | ||
Intervention format | Group | 11 | −0.42 | −0.92 to 0.08 | 0.25 |
Individual | 52 | −0.55 | −0.73 to −0.38 | ||
Intervention delivery | Clinician delivered | 43 | −0.63 | −0.87 to −0.38 | 4.50∗ |
Self-administered | 23 | −0.34 | −0.43 to −0.26 | ||
Country of origin | Australia | 5 | −1.50 | −2.39 to −0.60 | 53.69∗∗∗ |
Canada | 4 | −0.12 | −0.40 to 0.17 | ||
China | 8 | −0.85 | −1.59 to −0.11 | ||
Germany | 3 | −0.49 | −0.90 to −0.08 | ||
Korea | 4 | −0.78 | −1.70 to 0.15 | ||
Netherlands | 3 | −0.16 | −0.29 to −0.03 | ||
Sweden | 8 | −0.28 | −0.53 to −0.03 | ||
Taiwan | 4 | −0.57 | −0.61 to −0.52 | ||
UK | 9 | −0.36 | −0.51 to −0.22 | ||
USA | 20 | −0.50 | −0.71 to −0.28 | ||
New Zealandc | 2 | – | – | ||
Spainc | 1 | – | – |
Notes: CBTi = cognitive behavioural therapy for insomnia, MH = Mental Health, PH = Physical Health, TaU = treatment as usual, WLC = wait list control.
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Studies in the ‘No’ moderator category were excluded from the review due to having no significant effect on sleep quality but were included for moderation analysis.
The ‘exercise based’ category combines separate interventions with exercise as a key element, including walking, yoga and Tai Chi.
Not included in subgroup analysis due to low number.